Effectiveness of XBB.1.5 Vaccines against Symptomatic SARS-CoV-2 Infection in Older Adults during the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024Lore Merdrignac, Esther Kissling, Nuno Verdasca et al.|SSRN Electronic Journal|2024Cited by 1